Navigation Links
Nanotechnology being used to improve biocompatibility of human prosthetics and implants

As populations of the world age the current trend is that people are not slowing down in their later years. The desire for increased activity among the elderly also means increased demands on medical researchers to come up with better ways to keep them active. In the fields of implants and prosthetics calcium phosphate (CP) coatings on titanium alloy implants are proving their worth in orthopaedic and dental applications.

The most promising form of CP are hydroxyapatite (Ca10(PO4)6(OH)2, HA) coatings used to promote rapid bone remodelling on the titanium alloy implants. It is well known that the microstructure of these coatings significantly influences their mechanical properties and biocompatibility. Understanding the effect of nanostructures within a biocompatible coating could contribute greatly towards improving the effectiveness of these coatings.

In this study by Singaporean researchers, K.A. Khor, H. Li and P. Cheang, from Nanyang Technological University, the nanostructures and in vitro osteoblast behavior of individual CP splats were characterized. The splats were deposited using both plasma spraying and high velocity oxy-fuel (HVOF) onto polished Ti-6Al-4V substrates.

The results showed that the nanostructured HA splats are capable of enhancing the attachment and proliferation of the osteoblast cells. The study also revealed that the dissolution of the Ca/P-rich phases into the culture medium might promote the proliferation/differentiation of the osteoblast cells.


'"/>

Source:AZoNetwork


Page: 1

Related biology news :

1. Nanotechnology to provide portable genetic risk detection
2. Nanotechnology may find disease before it starts
3. Nanotechnology propels advances in regenerative medicine research
4. Nanotechnology shows promise as next wrinkle fighter
5. Nanotechnology meets biology and DNA finds its groove
6. Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed
7. When it comes to cell entry, being average has its advantages
8. Sperm stem cells closer to being like embryonic stem cells
9. Progress being made in exploring potential use of stem cells to treat heart disease
10. Fat stem cells being studied as option for breast reconstruction
11. DNA layer reduces risk of reserve parts being rejected
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: AWRE), ... that Richard P. Moberg has resigned, effective ... and Chief Financial Officer and Treasurer of Aware citing ... serve as a member of the Board of Directors ... Aware,s co-Chief Executive Officer and co-President, General Counsel has ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... ... exhibits both viscous and elastic characteristics when deformed, which is identical to how ... to gently absorb compressive forces and return to its natural state along a ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseqâ„¢ ... developed with input from industry experts to ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
Breaking Biology Technology: